BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8580075)

  • 1. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant.
    Ohashi T; Yamamura T; Inobe J; Kondo T; Kunishita T; Tabira T
    Int Immunol; 1995 Nov; 7(11):1771-8. PubMed ID: 8580075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences.
    Kondo T; Yamamura T; Inobe J; Ohashi T; Takahashi K; Tabira T
    Int Immunol; 1996 Jan; 8(1):123-30. PubMed ID: 8671596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects.
    Trotter JL; Pelfrey CM; Trotter AL; Selvidge JA; Gushleff KC; Mohanakumar T; McFarland HF
    J Neuroimmunol; 1998 Apr; 84(2):172-8. PubMed ID: 9628460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [T cell immunity to proteolipid protein (PLP) in multiple sclerosis (MS): identification of DR2-associated PLP determinants and conserved TCR CDR3 motifs].
    Kondo T; Ohashi T
    Nihon Rinsho; 1994 Nov; 52(11):2940-5. PubMed ID: 7527867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1993 Jul; 46(1-2):33-42. PubMed ID: 7689593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls.
    Pelfrey CM; Tranquill LR; Vogt AB; McFarland HF
    Mult Scler; 1996 Apr; 1(5):270-8. PubMed ID: 9345429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S; Fukaura H; Zhang J; al-Sabbagh A; Southwood S; Sette A; Kuchroo VK; Hafler DA
    J Immunol; 1995 Jul; 155(2):982-92. PubMed ID: 7541828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1994 Sep; 53(2):153-61. PubMed ID: 7520919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
    Fridkis-Hareli M; Santambrogio L; Stern JN; Fugger L; Brosnan C; Strominger JL
    J Clin Invest; 2002 Jun; 109(12):1635-43. PubMed ID: 12070311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects.
    Pender MP; Csurhes PA; Greer JM; Mowat PD; Henderson RD; Cameron KD; Purdie DM; McCombe PA; Good MF
    J Immunol; 2000 Nov; 165(9):5322-31. PubMed ID: 11046067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
    Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.